Evidence map›Paper›PMID 7717403›Full record

ArticleAmerican journal of human genetics1995

The 18q- syndrome: analysis of chromosomes by bivariate flow karyotyping and the PCR reveals a successive set of deletion breakpoints within 18q21.2-q22.2.

G A Silverman, S S Schneider, H F Massa, A Flint, M Lalande, J C Leonard, J Overhauser, G van den Engh, B J Trask

Open access · greenAbstract read
In one paragraph

Article in American journal of human genetics, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Chromosomes in the flow to simplify genome analysis.Functional & integrative genomics · 2012
    Review
  4. Article
  5. Article
  6. Article
  7. Molecular characterization of patients with 18q23 deletions.American journal of human genetics · 1997
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

G A SilvermanDepartment of Pediatrics, Harvard Medical School, Boston, MA, USA.
S S Schneider
H F Massa
A Flint
M Lalande
J C Leonard
J Overhauser
G van den Engh
B J Trask
Harvard University · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI CHEN, CHINFEI · 1985 to 2015
$26.2M
MOLECULAR ANALYSIS OF THE 18Q-SYNDROMER01HD028475 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI SILVERMAN, GARY ARTHUR · 1996 to 1999
–
MOLECULAR ANALYSIS OF THE 18Q-SYNDROMER29HD028475 · NICHD · WASHINGTON UNIVERSITY · PI SILVERMAN, GARY ARTHUR · 1991 to 1995
–
NICHD NIH HHS HD18655NICHD NIH HHS HD28475
6 · The paper itself

Abstract

The 18q- syndrome is one of several terminal deletion disorders that occur in humans. Previous G-banding studies suggest that the loss of a critical band, 18q21.3, results in mental retardation, craniofacial anomalies, and metabolic defects. However, it is difficult to reconcile the consistent loss of a single region with the large variability in clinical phenotype. The purpose of this study was to reassess the extent of chromosomal loss in a cohort of 17 18q- syndrome patients by using fluorescent-activated chromosome sorting, PCR, and FISH. Bivariate flow karyotypes revealed heterogeneity among the deletions; they ranged in size from 9 to 26 Mb. To confirm this heterogeneity at a molecular level, deleted and normal chromosomes 18 of six patients were collected by flow sorting, preamplified by random priming, and assayed for marker content by the PCR. This analysis defined five unique breakpoints among the six patients. We conclude that the terminal deletions in the 18q- syndrome occur over a broad region spanning the interval from 18q21.2 to 18q22.2. Our results suggest that the variability in clinical phenotype may be more representative of a contiguous-gene syndrome with a baseline deficit of 18q22.2-qter than of the loss of a single critical region within 18q21.3.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 18Flow CytometryHumansIn Situ Hybridization, FluorescenceKaryotypingPolymerase Chain ReactionSyndrome

Identifiers

PMID7717403
PMCPMC1801205
OpenAlexW15026420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.